These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 24482446)

  • 1. Temozolomide is an active agent in children with recurrent medulloblastoma/primitive neuroectodermal tumor: an Italian multi-institutional phase II trial.
    Cefalo G; Massimino M; Ruggiero A; Barone G; Ridola V; Spreafico F; Potepan P; Abate ME; Mascarin M; Garrè ML; Perilongo G; Madon E; Colosimo C; Riccardi R
    Neuro Oncol; 2014 May; 16(5):748-53. PubMed ID: 24482446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group.
    Nicholson HS; Kretschmar CS; Krailo M; Bernstein M; Kadota R; Fort D; Friedman H; Harris MB; Tedeschi-Blok N; Mazewski C; Sato J; Reaman GH
    Cancer; 2007 Oct; 110(7):1542-50. PubMed ID: 17705175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of temozolomide and topotecan (TOTEM) in children with relapsed or refractory extracranial and central nervous system tumors including medulloblastoma with post hoc Bayesian analysis: A European ITCC study.
    Le Teuff G; Castaneda-Heredia A; Dufour C; Jaspan T; Calmon R; Devos A; McHugh K; Leblond P; Frappaz D; Aerts I; Zwaan CM; Ducassou S; Chastagner P; Verschuur A; Corradini N; Casanova M; Rubie H; Riccardi R; Le Deley MC; Vassal G; Geoerger B;
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28032. PubMed ID: 31595663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of temozolomide for recurrent embryonal brain tumors in children.
    Wang CH; Hsu TR; Wong TT; Chang KP
    Childs Nerv Syst; 2009 May; 25(5):535-41. PubMed ID: 19107490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Craniospinal irradiation with concomitant and adjuvant temozolomide--a feasibility assessment of toxicity in patients with glioblastoma with a PNET component.
    O'Leary B; Mandeville HC; Fersht N; Solda F; Mycroft J; Zacharoulis S; Vaidya S; Saran F
    J Neurooncol; 2016 Apr; 127(2):295-302. PubMed ID: 26842817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temozolomide in resistant or relapsed pediatric solid tumors.
    De Sio L; Milano GM; Castellano A; Jenkner A; Fidani P; Dominici C; Donfrancesco A
    Pediatr Blood Cancer; 2006 Jul; 47(1):30-6. PubMed ID: 16047361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of O⁶-methylguanine-DNA methyltransferase in childhood medulloblastoma.
    Faoro D; von Bueren AO; Shalaby T; Sciuscio D; Hürlimann ML; Arnold L; Gerber NU; Haybaeck J; Mittelbronn M; Rutkowski S; Hegi M; Grotzer MA
    J Neurooncol; 2011 May; 103(1):59-69. PubMed ID: 20820873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy.
    Prados MD; Wara W; Edwards MS; Ater J; Rabbit J; Lamborn K; Davis R; Levin VA
    Pediatr Neurosurg; 1996 Oct; 25(4):174-81. PubMed ID: 9293544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temozolomide for recurrent low-grade spinal cord gliomas in adults.
    Chamberlain MC
    Cancer; 2008 Sep; 113(5):1019-24. PubMed ID: 18615600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temozolomide treatment of an adult with a relapsing medulloblastoma.
    Durando X; Thivat E; Gilliot O; Irthum B; Verrelle P; Vincent C; Bay JO
    Cancer Invest; 2007 Sep; 25(6):470-5. PubMed ID: 17882660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of temozolomide in children with recurrent high-grade glioma.
    Ruggiero A; Cefalo G; Garré ML; Massimino M; Colosimo C; Attinà G; Lazzareschi I; Maurizi P; Ridola V; Mazzarella G; Caldarelli M; Di Rocco C; Madon E; Abate ME; Clerico A; Sandri A; Riccardi R
    J Neurooncol; 2006 Mar; 77(1):89-94. PubMed ID: 16292488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I study of temozolomide combined with oral etoposide in children with recurrent or progressive medulloblastoma.
    Ruggiero A; Rizzo D; Attinà G; Lazzareschi I; Mastrangelo S; Maurizi P; Migliorati R; Bertolini P; Pastore M; Colosimo C; Riccardi R
    Eur J Cancer; 2010 Nov; 46(16):2943-9. PubMed ID: 20538454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temozolomide for treatment-resistant recurrent meningioma.
    Chamberlain MC; Tsao-Wei DD; Groshen S
    Neurology; 2004 Apr; 62(7):1210-2. PubMed ID: 15079029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of treatment of children with recurrent medulloblastoma/primitive neuroectodermal tumors with lomustine, cisplatin, and vincristine.
    Lefkowitz IB; Packer RJ; Siegel KR; Sutton LN; Schut L; Evans AE
    Cancer; 1990 Feb; 65(3):412-7. PubMed ID: 2153428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor study.
    Grill J; Geoerger B; Gesner L; Perek D; Leblond P; Cañete A; Aerts I; Madero L; de Toledo Codina JS; Verlooy J; Estlin E; Cisar L; Breazna A; Dorman A; Bailey S; Nicolin G; Grundy RG; Hargrave D;
    Neuro Oncol; 2013 Sep; 15(9):1236-43. PubMed ID: 23857707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temozolomide with irinotecan versus temozolomide, irinotecan plus bevacizumab for recurrent medulloblastoma of childhood: Report of a COG randomized Phase II screening trial.
    Levy AS; Krailo M; Chi S; Villaluna D; Springer L; Williams-Hughes C; Fouladi M; Gajjar A
    Pediatr Blood Cancer; 2021 Aug; 68(8):e29031. PubMed ID: 33844469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.
    Lanzetta G; Campanella C; Rozzi A; Nappa M; Costa A; Fedele F; Innocenzi G; Gagliardi FM; Salvati M; Minniti G; Frati A; Frati L; Vecchione A
    Anticancer Res; 2003; 23(6D):5159-64. PubMed ID: 14981983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic medulloblastoma in an adult; treatment with temozolomide.
    Poelen J; Bernsen HJ; Prick MJ
    Acta Neurol Belg; 2007 Jun; 107(2):51-4. PubMed ID: 17710841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse.
    Brada M; Hoang-Xuan K; Rampling R; Dietrich PY; Dirix LY; Macdonald D; Heimans JJ; Zonnenberg BA; Bravo-Marques JM; Henriksson R; Stupp R; Yue N; Bruner J; Dugan M; Rao S; Zaknoen S
    Ann Oncol; 2001 Feb; 12(2):259-66. PubMed ID: 11300335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I study of temozolomide in children and adolescents with recurrent solid tumors: a report from the Children's Cancer Group.
    Nicholson HS; Krailo M; Ames MM; Seibel NL; Reid JM; Liu-Mares W; Vezina LG; Ettinger AG; Reaman GH
    J Clin Oncol; 1998 Sep; 16(9):3037-43. PubMed ID: 9738573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.